A phase II study of capecitabine (Cape) or 5-fluorouracil (5-FU) with pegylated interferon alpha-2b (Peg-IFNA-2b) in unresectable/metastatic cutaneous squamous cell carcinoma (CSCC).
Jameel Muzaffar(Moffitt Cancer Center), Christine H. Chung(Moffitt Cancer Center), Kedar Kirtane(Moffitt Cancer Center), Nikhil I. Khushalani(Roswell Park Comprehensive Cancer Center), Janaki Parameswaran(Moffitt Cancer Center), Robbert J.C. Slebos(University of Iowa), Jeffery S. Russell(University of Utah), Janis V. de la Iglesia
Cited by 0
Related Papers
Proteogenomic characterization of human colon and rectal cancer
|Nature|2014|1.6k
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
|New England Journal of Medicine|2008|1.5k
Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
|Cell Metabolism|2012|1.1k